STOCK TITAN
  1. Home
  2. Sec-filings
  3. BSX
  4. [EFFECT] BOSTON SCIENTIFIC CORP SEC Filing

[EFFECT] BOSTON SCIENTIFIC CORP SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 1, 2026 9:00 A.M.
Form: S-4
CIK: 0000885725
Company Name: BOSTON SCIENTIFIC CORP
File Number: 333-293872

Source: View Original Filing on SEC EDGAR

Boston Scien Cp

NYSE:BSX

View BSX Stock Overview →

BSX Rankings

#165 Ranked by Market Cap
N/A Ranked by Dividends
#1860 52-Week Gainer
#1970 YTD Gainer
#537 Monthly Gainer
#1821 Ranked by Short %Change

BSX Latest News

Mar 30, 2026
Boston Scientific announces conference call discussing first quarter 2026 results
Mar 30, 2026
Boston Scientific receives FDA clearance for the Asurys™ Fluid Management System
Mar 28, 2026
CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints
Mar 28, 2026
HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism
Mar 12, 2026
BSX Lawsuit Alleges Claims Executives Misrepresented U.S. Electrophysiology Volumes - BOSTON SCIENTIFIC CORPORATION Investors Face Losses Following Claims Executives Misrepresented U.S. Electrophysiology Volumes: SueWallSt

BSX Latest SEC Filings

Apr 1, 2026
[424B3] BOSTON SCIENTIFIC CORP Prospectus Filed Pursuant to Rule 424(b)(3)
Mar 30, 2026
[S-4/A] BOSTON SCIENTIFIC CORP Amended Business Combination Registration
Mar 30, 2026
[8-K] BOSTON SCIENTIFIC CORP Reports Material Event
Mar 26, 2026
[SCHEDULE 13G/A] BOSTON SCIENTIFIC CORP Amended Passive Investment Disclosure
Mar 18, 2026
[DEF 14A] BOSTON SCIENTIFIC CORP Definitive Proxy Statement

BSX Stock Data

93.36B
1.48B
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MARLBOROUGH